cnk-10q_20180331.htm

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐ (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 30, 2018, 116,778,802 shares of common stock were issued and outstanding.

Certain matters within this Quarterly Report on Form 10Q include “forward–looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The “forward-looking statements” may include our current expectations, assumptions, estimates and projections about our business and our industry. They may include statements relating to future revenues, expenses and profitability, the future development and expected growth of our business, projected capital expenditures, attendance at movies generally or in any of the markets in which we operate, the number or diversity of popular movies released and our ability to successfully license and exhibit popular films, national and international growth in our industry, competition from other exhibitors and alternative forms of entertainment and determinations in lawsuits in which we are defendants. Forward-looking statements can be identified by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. For a description of the risk factors, please review the “Risk Factors” section or other sections in the Company’s Annual Report on Form 10-K filed February 23, 2018 and quarterly reports on Form 10-Q, filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such risk factors. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

	March 31,			December 31,
	2018			2017
Assets
Current assets
Cash and cash equivalents	$	474,046		$	522,547
Inventories		17,083			17,507
Accounts receivable		78,211			89,250
Current income tax receivable		2,991			11,730
Prepaid expenses and other		19,409			16,536
Total current assets		591,740			657,570

Theatre properties and equipment		3,387,494			3,328,589
Less: accumulated depreciation and amortization		1,551,842			1,500,535
Theatre properties and equipment, net		1,835,652			1,828,054

Other assets
Goodwill		1,283,945			1,284,079
Intangible assets - net		335,164			336,761
Investment in NCM		202,455			200,550
Investments in and advances to affiliates		118,789			120,045
Long-term deferred tax asset		4,103			4,067
Deferred charges and other assets - net		41,623			39,767
Total other assets		1,986,079			1,985,269

Total assets	$	4,413,471		$	4,470,893

Liabilities and equity

Current liabilities
Current portion of long-term debt	$	7,984		$	7,099
Current portion of capital lease obligations		26,231			25,511
Current income tax payable		11,058			5,509
Current liability for uncertain tax positions		12,353			11,873
Accounts payable and accrued expenses		329,723			418,921
Total current liabilities		387,349			468,913

Long-term liabilities
Long-term debt, less current portion		1,775,252			1,780,381
Capital lease obligations, less current portion		245,798			251,151
Long-term deferred tax liability		134,732			121,787
Long-term liability for uncertain tax positions		13,258			8,358
Deferred lease expenses		40,489			40,929
Deferred revenue - NCM		299,222			351,706
Other long-term liabilities		45,380			41,980
Total long-term liabilities		2,554,131			2,596,292

Commitments and contingencies (see Note 17)

Equity
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock, $0.001 par value: 300,000,000 shares authorized, 121,385,985 shares issued and 116,778,802 shares outstanding at March 31, 2018 and 121,000,903 shares issued and 116,475,033 shares outstanding at December 31, 2017		121			121
Additional paid-in-capital		1,144,514			1,141,088
Treasury stock, 4,607,183 and 4,525,870 shares, at cost, at March 31, 2018 and December 31, 2017, respectively		(79,049	)		(76,354	)
Retained earnings		647,298			582,222
Accumulated other comprehensive loss		(252,942	)		(253,282	)
Total Cinemark Holdings, Inc.'s stockholders' equity		1,459,942			1,393,795
Noncontrolling interests		12,049			11,893
Total equity		1,471,991			1,405,688

Total liabilities and equity	$	4,413,471		$	4,470,893

The accompanying notes are an integral part of the condensed consolidated financial statements.

	Three Months Ended March 31,
	2018			2017
Revenues
Admissions	$	452,624		$	476,469
Concession		261,772			268,224
Other		65,575			34,917
Total revenues		779,971			779,610

Cost of operations
Film rentals and advertising		240,915			252,818
Concession supplies		40,824			42,100
Salaries and wages		93,158			84,201
Facility lease expense		82,091			84,262
Utilities and other		109,432			88,357
General and administrative expenses		42,384			38,216
Depreciation and amortization		64,395			57,356
Impairment of long-lived assets		591			273
Loss on sale of assets and other		3,939			834
Total cost of operations		677,729			648,417

Operating income		102,242			131,193

Other income (expense)
Interest expense		(27,115	)		(26,369	)
Loss on debt amendments		(1,484	)		—
Interest income		2,238			1,333
Foreign currency exchange gain		1,378			1,589
Distributions from NCM		6,358			6,788
Interest expense - NCM		(4,979	)		—
Equity in income of affiliates		8,636			10,060
Total other expense		(14,968	)		(6,599	)

Income before income taxes		87,274			124,594
Income taxes		25,097			44,400
Net income	$	62,177		$	80,194
Less: Net income attributable to noncontrolling interests		156			466
Net income attributable to Cinemark Holdings, Inc.	$	62,021		$	79,728

Weighted average shares outstanding
Basic		115,883			115,629
Diluted		116,143			115,915

Earnings per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic	$	0.53		$	0.68
Diluted	$	0.53		$	0.68

Dividends declared per common share	$	0.32		$	0.29

The accompanying notes are an integral part of the condensed consolidated financial statements.

	Three Months Ended March 31,
	2018			2017
Operating activities
Net income	$	62,177		$	80,194
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		63,514			56,975
Amortization of intangible and other assets and favorable/unfavorable leases		881			381
Amortization of long-term prepaid rents		639			493
Amortization of debt issue costs		1,590			1,529
Loss on debt amendments		1,484			—
Amortization of deferred revenues, deferred lease incentives and other		(5,343	)		(3,822	)
Impairment of long-lived assets		591			273
Share based awards compensation expense		3,426			3,241
Loss on sale of assets and other		3,939			834
Deferred lease expenses		(483	)		(347	)
Equity in income of affiliates		(8,636	)		(10,060	)
Deferred income tax expenses		(72	)		8,889
Distributions from equity investees		12,323			12,049
Changes in assets and liabilities and other		(52,378	)		(64	)
Net cash provided by operating activities		83,652			150,565

Investing activities
Additions to theatre properties and equipment		(80,163	)		(91,187	)
Proceeds from sale of theatre properties and equipment and other		477			3,835
(Investment in) return of investment from joint ventures and other, net		764			(228	)
Net cash used for investing activities		(78,922	)		(87,580	)

Financing activities
Dividends paid to stockholders		(37,346	)		(33,760	)
Payroll taxes paid as a result of restricted stock withholdings		(2,695	)		(2,694	)
Repayments of long-term debt		(1,649	)		—
Payment of debt issue costs		(4,962	)		—
Fees paid related to debt amendments		(704	)		—
Payments on capital leases		(6,090	)		(4,989	)
Other		—			(294	)
Net cash used for financing activities		(53,446	)		(41,737	)

Effect of exchange rate changes on cash and cash equivalents		215			1,835

Increase (decrease) in cash and cash equivalents		(48,501	)		23,083

Cash and cash equivalents:
Beginning of period		522,547			561,235
End of period	$	474,046		$	584,318

Supplemental information (see Note 14)

The accompanying notes are an integral part of the condensed consolidated financial statements.

Cinemark Holdings, Inc. and subsidiaries (the “Company”) operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

The accompanying condensed consolidated balance sheet as of December 31, 2017, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.

These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Annual Report on Form 10-K filed February 23, 2018 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three months ended March 31, 2018 are not necessarily indicative of the results to be achieved for the full year.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC Topic 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASC Topic 606 replaces most existing revenue recognition guidance in U.S. generally accepted accounting principles. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from the contracts with customers. The Company adopted ASC Topic 606 effective January 1, 2018. See Note 3 for further discussion.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), (“ASU 2016-02”). The purpose of ASU 2016-02 is to provide financial statement users a better understanding of the amount, timing, and uncertainty of cash flows arising from leases. The adoption of ASU 2016-02 will result in the recognition of a right-of-use asset and a lease liability for most operating leases. New disclosure requirements include qualitative and quantitative information about the amounts recorded in the financial statements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. ASU 2016-02 requires a modified retrospective transition by means of a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year in which the guidance is effective with the option to elect certain practical expedients. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2016-02 on its condensed consolidated financial statements. The most significant impact of the amendments in ASU 2016-02 will be the recognition of new right-of-use assets and lease liabilities for assets currently subject to operating leases. The Company will adopt the amendments in ASU 2016-02 in the first quarter of 2019.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force, (“ASU 2016-15”). The purpose of ASU 2016-15 is to reduce the diversity in practice regarding how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year. A retrospective transition method should be used in the application of the amendments within ASU 2016-15. The Company adopted ASU 2016-15 effective January 1, 2018. ASU 2016-15 did not have a material impact on the Company’s condensed consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, (“ASU 2016-16”). The purpose of ASUS 2016-16 is to improve the accounting for the income tax consequences of intra-

entity transfers of assets other than inventory. ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year. A modified retrospective transition method should be used in the application of the amendments within ASU 2016-16 with a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. ASU 2016-16 did not have a material impact on the Company’s condensed consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope Modification Accounting, (“ASU 2017-09”). The amendments in ASU 2017-09 provide guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting as described in ASC Topic 718. The amendments should be applied on a prospective basis. ASU 2017-09 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year. Early adoption is permitted. The Company adopted ASU 2017-09 effective January 1, 2018. ASU 2017-09 did not have a material impact on the Company’s condensed consolidated financial statements.

Admissions and concession revenues are recognized when sales are made at the box office and concession stand, respectively. Other revenues include screen advertising and other ancillary revenues such as vendor marketing promotions, meeting rentals and electronic video games located in the Company’s theatres. The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. Additionally, the Company recognizes unredeemed gift cards and other advanced sale-type certificates as a proportion of actual redemptions as other revenues, which is an estimate primarily based on the Company’s historical experience with such cards and certificates.

Screen advertising revenues are generally recognized over the period that the related advertising is delivered on-screen or in-theatre. Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts.

See additional revenue recognition policy considerations, updated for the adoption of ASC Topic 606, below.

The Company adopted ASC 606, Revenue from Contracts with Customers, effective January 1, 2018 under the modified retrospective method (cumulative-effect) and therefore, revenue amounts as presented on the condensed consolidated statements of income have not been adjusted for prior periods presented.

Changes to the way in which the Company recognizes revenue resulted in the following impacts to the condensed consolidated statements of income:

The above noted changes increased (decreased) admissions, concession and other revenue by ($1,302), ($545) and $27,459, respectively, for the three months ended March 31, 2018.

The Company applied the practical expedient to exclude sales and other similar taxes collected from customers from its transaction price for purposes of recording revenues, as such revenues are presented net of such taxes.

The following table presents revenues for the three months ended March 31, 2018, disaggregated based on major type of good or service and by reportable operating segment.

The following table presents revenues for the three months ended March 31, 2018, disaggregated based on timing of revenue recognition (see Revenue Recognition Policy above).

The following table presents changes in the Company’s deferred revenues for the three months ended March 31, 2018.

Deferred Revenues	Deferred Revenue - NCM			Other Deferred Revenues ⁽¹⁾			Total
Balance at January 1, 2018	$	351,706		$	86,498		$	438,204
Impact of adoption of ASC Topic 606		(53,605	)		—			(53,605	)
Amounts recognized as accounts receivable		—			9,119			9,119
Cash received from customers in advance		—			22,271			22,271
Common units received from NCM (see Note 7)		5,012			—			5,012
Revenue recognized during period		(3,891	)		(33,613	)		(37,504	)
Foreign currency translation adjustments		—			(75	)		(75	)
Balance at March 31, 2018	$	299,222		$	84,200		$	383,422

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of March 31, 2018 and when the Company expects to recognize this revenue.

	Twelve Months Ended March 31,
Remaining Performance Obligations	2019		2020		2021		2022		2023		Thereafter		Total
Deferred revenue - NCM	$	15,831	$	15,831	$	15,831	$	15,831	$	15,831	$	220,067	$	299,222
Deferred revenue - other		73,338		10,799		63		—		—		—		84,200
Total	$	89,169	$	26,630	$	15,894	$	15,831	$	15,831	$	220,067	$	383,422

Accounts receivable as of March 31, 2018 included approximately $47,539 of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the three months ended March 31, 2018.

As discussed further in Note 7, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2037. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. See Note 7 for additional information regarding the common unit adjustment and related accounting. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606.

As a result of the significant financing component on deferred revenue - NCM, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $4,979 during the three months ended March 31, 2018. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 5.5% to 8.0%.

The Company considers its unvested restricted stock awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two class method and the treasury stock method.

The following table presents computations of basic and diluted earnings per share under the two-class method:

	Three Months Ended
	March 31,
	2018			2017
Numerator:
Net income attributable to Cinemark Holdings, Inc.	$	62,021		$	79,728
Earnings allocated to participating share-based awards ⁽¹⁾		(297	)		(382	)
Net income attributable to common stockholders	$	61,724		$	79,346

Denominator (shares in thousands):
Basic weighted average common stock outstanding		115,883			115,629
Common equivalent shares for restricted stock units		260			286
Diluted		116,143			115,915

Basic earnings per share attributable to common stockholders	$	0.53		$	0.68
Diluted earnings per share attributable to common stockholders	$	0.53		$	0.68

On March 29, 2018, Cinemark USA, Inc., our wholly-owned subsidiary, amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The Company incurred debt issue costs of approximately $4,962 in connection with the amendment, which are reflected as a reduction of long term debt on the condensed consolidated balance sheet as of March 31, 2018. As a result of the amendment, the Company wrote-off $780 of unamortized debt issue costs and incurred approximately $704 in legal and other fees, both of which are reflected as loss on debt amendments on the condensed consolidated statements of income for the three months ended March 31, 2018.

The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”). The carrying value of the Company’s long-term debt was $1,815,646 and $1,817,295 as of March 31, 2018 and December 31, 2017, respectively, excluding unamortized debt discounts and debt issue costs. The fair value of the Company’s long-term debt was $1,814,853 and $1,840,918 as of March 31, 2018 and December 31, 2017, respectively.

Below is a summary of changes in stockholders’ equity attributable to Cinemark Holdings, Inc., noncontrolling interests and total equity for the three months ended March 31, 2018 and 2017:

	Cinemark
	Holdings, Inc.
	Stockholders’			Noncontrolling		Total
	Equity			Interests		Equity
Balance at January 1, 2018	$	1,393,795		$	11,893	$	1,405,688
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)		40,526			—		40,526
Share based awards compensation expense		3,426			—		3,426
Stock withholdings related to share based awards that vested during the three months ended March 31, 2018		(2,695	)		—		(2,695	)
Dividends paid to stockholders ⁽¹⁾		(37,346	)		—		(37,346	)
Dividends accrued on unvested restricted stock unit awards ⁽¹⁾		(125	)		—		(125	)
Net income		62,021			156		62,177
Other comprehensive income in equity method investees		136			—		136
Foreign currency translation adjustments		204			—		204
Balance at March 31, 2018	$	1,459,942		$	12,049	$	1,471,991

	Cinemark
	Holdings, Inc.
	Stockholders’			Noncontrolling			Total
	Equity			Interests			Equity
Balance at January 1, 2017	$	1,261,818		$	11,142		$	1,272,960
Share based awards compensation expense		3,241		―				3,241
Stock withholdings related to share based awards that vested during the three months ended March 31, 2017		(2,694	)	―				(2,694	)
Dividends paid to stockholders ⁽²⁾		(33,760	)	―				(33,760	)
Dividends accrued on unvested restricted stock unit awards ⁽²⁾		(153	)	―				(153	)
Dividends paid to noncontrolling interests	―				(294	)		(294	)
Net income		79,728			466			80,194
Other comprehensive income in equity method investees		198		―				198
Foreign currency translation adjustments		13,342		―				13,342
Balance at March 31, 2017	$	1,321,720		$	11,314		$	1,333,034

The Company has an investment in NCM. NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. Upon joining NCM, the Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM provides advertising and promotions to our theatres. As described further in Note 5 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, on February 13, 2007, NCMI, an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. Following the NCM, Inc. IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future

net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

							Distributions									Interest
	Investment			Deferred			from			Equity in			Other			Expense -		Cash
	in NCM			Revenue			NCM			Earnings			Revenue			NCM ⁽³⁾		Received
Balance as of January 1, 2018	$	200,550		$	(351,706	)
Impact of adoption of ASC Topic 606 ⁽¹⁾		—			53,605		$	—		$	—		$	—		$	—	$	—
Receipt of common units due to annual common unit adjustment ("CUA")		5,012			(5,012	)		—			—			—			—		—
Revenues earned under ESA ^{(2) (3)}		—			—			—			—			(7,967	)		4,979		2,988
Receipt of excess cash distributions		(7,122	)		—			(6,358	)		—			—			—		13,480
Equity in earnings		4,015			—			—			(4,015	)		—			—		—
Amortization of deferred revenue		—			3,891			—			—			(3,891	)		—		—
Balance as of and for the three months ended March 31, 2018	$	202,455		$	(299,222	)	$	(6,358	)	$	(4,015	)	$	(11,858	)	$	4,979	$	16,468

During the three months ended March 31, 2018 and 2017 the Company recorded equity in earnings of $4,015 and $3,241, respectively.

The Company made payments to NCM of $52 and $18 during the three months ended March 31, 2018 and 2017, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre properties and equipment on the condensed consolidated balance sheets.

Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC Entertainment, Inc. (“AMC”) and Regal Entertainment Group (“Regal”) (collectively, “Founding Members”), annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As further discussed in Note 5 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis.

During March 2018, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2018, the Company received an additional 908,042 common units of NCM, each of which is convertible into one share of NCM, Inc. common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $5,012. The fair value of the common units received was estimated based on the market price of NCM, Inc. stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The deferred revenue will be recognized on a straight-line basis over the remaining term of the ESA, which is approximately 19 years.

As of March 31, 2018, the Company owned a total of 28,779,904 common units of NCM, representing an ownership interest of approximately 18%. The estimated fair value of the Company’s investment in NCM was approximately $149,368 based on NCM, Inc.’s stock price as of March 30, 2018 of $5.19 per share (Level 1 input as defined in FASB ASC Topic 820), which was less than the

Company’s carrying value of $202,455. The Company does not believe that the decline in NCM, Inc.’s stock price is other than temporary and therefore, no impairment of the Company’s investment in NCM was recorded during the three months ended March 31, 2018. The market value of NCM, Inc.’s stock price may change due to the performance of the business, industry trends, general and economic conditions and other factors.

Below is a summary of activity for each of the Company’s other investments for the three months ended March 31, 2018:

	DCIP			AC JV, LLC		DCDC			Other			Total
Balance at January 1, 2018	$	106,215		$	5,916	$	3,598		$	4,316		$	120,045
Cash contributions made		326			—		—			78			404
Cash distributions received		(5,201	)		—		—			—			(5,201	)
Equity in income		4,142			253		226			—			4,621
Equity in other comprehensive income		136			—		—			—			136
Other		—			—		(1,168	)		(48	)		(1,216	)
Balance at March 31, 2018	$	105,618		$	6,169	$	2,656		$	4,346		$	118,789

On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of March 31, 2018, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting.

As of March 31, 2018, the Company had 3,817 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three months ended March 31, 2018 and 2017:

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $2,571 and $3,369 for the three months ended March 31, 2018 and 2017, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. Additionally, the remaining outstanding balance of a note payable from the Company to NCM, related to the formation of AC, was $2,778 as of March 31, 2018.

Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal. DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $234 and $278 to DCDC during the three months ended March 31, 2018 and 2017, respectively, related to content delivery services provided by DCDC. These fees are included in film rentals and advertising costs on the condensed consolidated statements of income.

Treasury Stock — Treasury stock represents shares of common stock repurchased or withheld by the Company and not yet retired. The Company has applied the cost method in recording its treasury shares. Below is a summary of the Company’s treasury stock activity for the three months ended March 31, 2018:

As of March 31, 2018, the Company had no plans to retire any shares of treasury stock.

Restricted Stock – During the three months ended March 31, 2018, the Company granted 260,019 shares of restricted stock to employees. The fair value of the restricted stock granted was determined based on the market value of the Company’s common stock on the date of grant, which was $39.03 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Certain of the restricted stock awards vest over two years and certain awards vest over four years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Below is a summary of restricted stock activity for the three months ended March 31, 2018:

As of March 31, 2018, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $20,005 and the weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Restricted Stock Units – During the three months ended March 31, 2018, the Company granted restricted stock units representing 224,602 hypothetical shares of common stock to employees. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2019 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 7%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 9.5%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 13%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All restricted stock units granted during 2018 will vest subject to an additional two-year service requirement and will be paid in the form of common stock if the participant continues to provide services through February 2022, which is the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest.

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the three months ended March 31, 2018 at each of the three target levels of financial performance (excluding forfeiture assumptions):

Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2018 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of the Company’s common stock on the date of grant, which was $39.03 per share. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period.

During the three months ended March 31, 2018, the Company determined that the IRR reached for the restricted stock units granted in February 2016 was 7.2%, compared to a target IRR of 8.0%. The Company recorded a reduction in compensation expense of $69 during the three months ended March 31, 2018 to reflect the revised number of shares expected to vest in February 2020 for the 2016 restricted stock unit grant.

As of March 31, 2018, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $10,776. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of March 31, 2018, the Company had restricted stock units outstanding that represented a total of 596,726 hypothetical shares of common stock, net of actual cumulative forfeitures of 13,690 units, assuming an IRR of 7.2% was achieved for the 2016 grants and the maximum IRR level is achieved for all other grants outstanding.

The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for

impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). For the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment on all reporting units, in accordance with ASC Topic 350-20-35. No events or changes in circumstances occurred during the three months ended March 31, 2018 that indicated the carrying value of goodwill might exceed its estimated fair value.

	Balance at									Balance at
	January 1,									March 31,
	2018			Amortization			Other ⁽¹⁾			2018
Intangible assets with finite lives:
Gross carrying amount	$	105,895		$	—		$	(125	)	$	105,770
Accumulated amortization		(68,869	)		(1,495	)		-			(70,364	)
Total net intangible assets with finite lives	$	37,026		$	(1,495	)	$	(125	)	$	35,406

Intangible assets with indefinite lives:
Tradename		299,735		―			23				299,758
Total intangible assets — net	$	336,761		$	(1,495	)	$	(102	)	$	335,164

For the year ended December 31, 2017, the Company performed a quantitative assessment for all definite and indefinite-lived tradename assets. No events or changes in circumstances occurred during the three months ended March 31, 2018 that indicated the carrying value of its tradename assets might exceed their estimated fair values.

Estimated aggregate future amortization expense for intangible assets is as follows:

The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K. As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the three months ended March 31, 2018 and 2017. As of March 31, 2018, the estimated aggregate fair value of the long-lived assets impaired during the three months ended March 31, 2018 was $590.

The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre.

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

The Company did not have any assets or liabilities measured at fair value on a recurring basis under ASC Topic 820 as of December 31, 2017 or March 31, 2018.

The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 10 and Note 11). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed February 23, 2018. There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2018.

The accumulated other comprehensive loss account in stockholders’ equity of $252,942 and $253,282 as of March 31, 2018 and December 31, 2017, respectively, primarily includes cumulative foreign currency adjustments of $253,361 and $253,565, respectively, from translating the financial statements of the Company’s international subsidiaries.

All foreign countries where the Company has operations are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss.

A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. There has been a steady devaluation of the Argentine peso relative to the U.S. dollar in recent years. As of March 31, 2018, the Company did not designate Argentina as highly inflationary for accounting purposes. The Company will continue to monitor Argentina’s inflation rates on a quarterly basis to determine whether remeasurement is necessary.

Below is a summary of the impact of translating the March 31, 2018 financial statements of the Company’s international subsidiaries:

					Other
					Comprehensive
					Income (Loss) for the
	Exchange Rate as of				Three Months Ended
Country	March 31, 2018		December 31, 2017		March 31, 2018
Brazil		3.31		3.31	$	391
Argentina		20.16		18.65		(3,541	)
Colombia		2,780.47		2,936.67		1,887
Chile		604.40		615.97		1,207
All other						260
					$	204

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments.

Below is a breakdown of selected financial information by reportable operating segment:

	Three Months Ended
	March 31,
	2018			2017
Revenues
U.S.	$	599,645		$	581,209
International		183,628			202,068
Eliminations		(3,302	)		(3,667	)
Total revenues	$	779,971		$	779,610

Adjusted EBITDA
U.S.	$	155,844		$	164,654
International		37,586			47,226
Total Adjusted EBITDA	$	193,430		$	211,880

Capital expenditures
U.S.	$	69,971		$	78,817
International		10,192			12,370
Total capital expenditures	$	80,163		$	91,187

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

	Three Months Ended
	March 31,
	2018			2017
Net income	$	62,177		$	80,194
Add (deduct):
Income taxes		25,097			44,400
Interest expense ⁽¹⁾		27,115			26,369
Other income ⁽²⁾		(7,273	)		(12,982	)
Loss on debt amendments		1,484			-
Other cash distributions from equity investees ⁽³⁾		12,323			12,049
Depreciation and amortization		64,395			57,356
Impairment of long-lived assets		591			273
Loss on sale of assets and other		3,939			834
Deferred lease expenses		(483	)		(347	)
Amortization of long-term prepaid rents		639			493
Share based awards compensation expense		3,426			3,241
Adjusted EBITDA ⁽⁴⁾	$	193,430		$	211,880

The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is the Company’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of the Company’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $141 and $141 of management fee revenues during the three months ended March 31, 2018 and 2017, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the three months ended March 31, 2018 and 2017, the aggregate amounts paid to Copper Beech for the use of the aircraft was $14 and $15, respectively.

The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of the Company’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the three months ended March 31, 2018 and 2017, the Company paid total rent of approximately $7,880 and $7,326, respectively, to Syufy.

Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for damages and attorney’s fees arising from employee wage and hour claims under California law for alleged meal period, rest break, reporting time pay, unpaid wages, pay upon termination, and wage statements violations. The claims are also asserted as a representative action under the California Private Attorney General Act (“PAGA”). The Company denies the claims, denies that class certification is appropriate and denies that a PAGA representative action is appropriate, and is vigorously defending against the claims. The Company denies any violation of law and plans to vigorously defend against all claims. The Court recently determined that class certification is not appropriate and determined that a PAGA representative action is not appropriate. The plaintiff has appealed these rulings. The Company is unable to predict the outcome of this litigation or the range of potential loss.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. The Company has denied Plaintiff’s allegations and is vigorously defending these claims. The Company is unable to predict the outcome of this litigation or the range of potential loss.

The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

From time to time, the Company is involved in various other legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts LLC (“Joint Venture”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. The Joint Venture will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in the Joint Venture. The Company will account for its investment in the Joint Venture under the equity method of accounting.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes and schedules included elsewhere in this report.

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of March 31, 2018, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 15 to our condensed consolidated financial statements.

We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising sales and other revenue streams, such as vendor marketing promotions, meeting rentals and electronic video games located in some of our theatres. NCM provides our domestic theatres with various forms of in theatre advertising. We also offer alternative entertainment, such as live and pre-recorded sports programs, concert events, the Metropolitan Opera, in-theatre gaming and other special events in our theatres through AC JV, LLC. Our Flix Media subsidiaries have also allowed us to expand our screen advertising and alternative content within our international circuit and to other international exhibitors.

Films leading the box office during the three months ended March 31, 2018 included the carryover of Jumanji: Welcome to the Jungle, The Greatest Showman and Star Wars: The Last Jedi and new releases such as Black Panther, Peter Rabbit, Ready Player One, Fifty Shades Freed and other films. Films scheduled for release during the remainder of 2018 include well-known franchise films such as Avengers: Infinity War, Jurassic World: Fallen Kingdom, Solo: A Star Wars Story, The Incredibles 2, Deadpool 2, Ralph Breaks the Internet: Wreck-It Ralph 2, Fantastic Beasts: The Crimes of Grindelwald, Mission Impossible - Fallout, Hotel Transylvania 3: Summer Vacation and Ant-Man and the Wasp, among other films.

Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and renovated theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenues. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.

Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. In some international locations, staffing levels are also subject to local regulations.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under capital leases and the number of fee-owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, expenses for projection and sound equipment maintenance and monitoring, property taxes, janitorial costs, repairs, maintenance and security services.

General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company, including salaries and wages, incentive compensation and benefit costs for our corporate office personnel, facility expenses for our corporate offices, professional fees, audit fees, supplies and other costs that are not specifically associated with the operations of our theatres.

During April 2018, we, through our wholly-owned indirect subsidiary CNMK, formed a joint venture, FE Concepts LLC, with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. The Joint Venture will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. We and AWSR each invested approximately $20 million and each have a 50% voting interest in the Joint Venture. We will account for our investment in the Joint Venture under the equity method of accounting.

We adopted ASC Topic 606 effective January 1, 2018, therefore, our revenue recognition policy has been modified as discussed in Note 3 to the condensed consolidated financial statements.

The following table sets forth, for the periods indicated, certain operating data and the percentage of revenues represented by certain items reflected in our condensed consolidated statements of income.

	Three Months Ended
	March 31,
	2018			2017
Operating data (in millions):
Revenues
Admissions	$	452.6		$	476.5
Concession		261.8			268.2
Other		65.6			34.9
Total revenues	$	780.0		$	779.6
Cost of operations
Film rentals and advertising		241.0			252.8
Concession supplies		40.8			42.1
Salaries and wages		93.1			84.2
Facility lease expense		82.1			84.3
Utilities and other		109.4			88.4
General and administrative expenses		42.4			38.2
Depreciation and amortization		64.4			57.3
Impairment of long-lived assets		0.6			0.3
Loss on sale of assets and other		3.9			0.8
Total cost of operations		677.7			648.4
Operating income	$	102.3		$	131.2

Operating data as a percentage of total revenues:
Revenues
Admissions		58.0	%		61.1	%
Concession		33.6	%		34.4	%
Other		8.4	%		4.5	%
Total revenues		100.0	%		100.0	%
Cost of operations ⁽¹⁾
Film rentals and advertising		53.2	%		53.1	%
Concession supplies		15.6	%		15.7	%
Salaries and wages		11.9	%		10.8	%
Facility lease expense		10.5	%		10.8	%
Utilities and other		14.0	%		11.3	%
General and administrative expenses		5.4	%		4.9	%
Depreciation and amortization		8.3	%		7.3	%
Impairment of long-lived assets		0.1	%		—	%
Loss on sale of assets and other		0.5	%		0.1	%
Total cost of operations		86.9	%		83.2	%
Operating income		13.1	%		16.8	%
Average screen count (month end average)		5,959			5,898
Average operating screen count (month end average)		5,879			5,792
Total revenues per average screen (dollars)	$	130,890		$	132,182

Revenues. Total revenues increased $0.4 million to $780.0 million for the three months ended March 31, 2018 (“first quarter of 2018”) from $779.6 million for the three months ended March 31, 2017 (“first quarter of 2017”), representing a 0.1% increase. The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the three months ended March 31, 2018 and 2017.

	U.S. Operating Segment							International Operating Segment												Consolidated
															Constant Currency ⁽³⁾
	2018		2017		% Change			2018		2017		% Change			2018		% Change			2018		2017		% Change
Admissions revenues ⁽¹⁾	$	349.3	$	356.2		(1.9	)%	$	103.3	$	120.3		(14.1	)%	$	107.7		(10.5	)%	$	452.6	$	476.5		(5.0	)%
Concession revenues ⁽¹⁾	$	203.8	$	203.4		0.2	%	$	58.0	$	64.8		(10.5	)%	$	60.1		(7.3	)%	$	261.8	$	268.2		(2.4	)%
Other revenues ⁽¹⁾⁽²⁾	$	43.3	$	18.0		140.6	%	$	22.3	$	16.9		32.0	%	$	23.8		40.8	%	$	65.6	$	34.9		88.0	%
Total revenues ⁽¹⁾⁽²⁾	$	596.4	$	577.6		3.3	%	$	183.6	$	202.0		(9.1	)%	$	191.6		(5.1	)%	$	780.0	$	779.6		0.1	%
Attendance ⁽¹⁾		44.6		46.5		(4.1	)%		23.9		27.8		(14.0	)%							68.5		74.3		(7.8	)%
Average ticket price ⁽¹⁾	$	7.83	$	7.66		2.2	%	$	4.32	$	4.33		(0.2	)%	$	4.51		4.2	%	$	6.61	$	6.41		3.1	%
Concession revenues per patron ⁽¹⁾	$	4.57	$	4.37		4.6	%	$	2.43	$	2.33		4.3	%	$	2.51		7.7	%	$	3.82	$	3.61		5.8	%

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the three months ended March 31, 2018 and 2017.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2018		2017		2018		2017		Constant Currency 2018 ⁽¹⁾		2018		2017
Film rentals and advertising	$	192.9	$	196.4	$	48.1	$	56.4	$	50.2	$	241.0	$	252.8
Concession supplies		28.5		28.1		12.3		14.0		12.8		40.8		42.1
Salaries and wages		71.7		63.2		21.4		21.0		22.7		93.1		84.2
Facility lease expense		61.0		61.4		21.1		22.9		21.7		82.1		84.3
Utilities and other		79.0		60.0		30.4		28.4		32.1		109.4		88.4

Salaries and wages increased to $71.7 million for the first quarter of 2018 from $63.2 million for the first quarter of 2017 primarily due to staffing at new and recently remodeled theatres, increases in minimum and other wages and increased insurance and other benefit costs. Facility lease expense decreased to $61.0 million for the first quarter of 2018 from $61.4 million for the first quarter of 2017 primarily due to decreased percentage rent due to the decline in admissions revenues. Utilities and other costs increased to $79.0 million for the first quarter of 2018 from $60.0 million for the first quarter of 2017 primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

Salaries and wages increased to $21.4 million ($22.7 million in constant currency) for the first quarter of 2018 compared to $21.0 million for the first quarter of 2017. The as reported increase was due to increased local currency wage rates primarily due to inflation and new theatres. Facility lease expense decreased to $21.1 million ($21.7 million in constant currency) for the first quarter of 2018 compared to $22.9 million for the first quarter of 2017. The as reported decrease was due to decreased percentage rent due to the decline in revenues. Utilities and other costs increased to $30.4 million ($32.1 million in constant currency) for the first quarter of 2018 compared to $28.4 million for the first quarter of 2017. The as reported increase was primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

General and Administrative Expenses. General and administrative expenses increased to $42.4 million for the first quarter of 2018 from $38.2 million for the first quarter of 2017. The increase was primarily due to increased salaries, insurance, benefits costs and professional fees.

Depreciation and Amortization. Depreciation and amortization expense increased to $64.4 million during the first quarter of 2018 compared to $57.3 million during the first quarter of 2017. The increase was primarily due to theatre remodels and new theatres.

Impairment of Long-Lived Assets. We recorded asset impairment charges on assets held and used of $0.6 million during the first quarter of 2018 compared to $0.3 million during the first quarter of 2017. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Impairment charges for the first quarter of 2018 impacted two of our twenty-seven reporting units. See Note 11 to our condensed consolidated financial statements.

Loss on Sale of Assets and Other. We recorded a loss on sale of assets and other of $3.9 million during the first quarter of 2018 compared to $0.8 million during the first quarter of 2017. Activity for the first quarter of 2018 and the first quarter of 2017 was primarily due to the retirement of assets related to theatre remodels.

Interest Expense. Interest costs incurred, including amortization of debt issue costs, were $27.1 million during the first quarter of 2018 compared to $26.4 million during the first quarter of 2017. The increase was primarily due to an increase in the variable rate at which our term loan accrues interest.

Loss on Debt Amendments. We recorded a loss on debt amendments of $1.4 million for the first quarter of 2018 related to amendments to our senior secured credit facility. See Note 5 to our condensed consolidated financial statements for further discussion.

Distributions from NCM. We recorded distributions from NCM of $6.4 million during the first quarter of 2018 compared to $6.8 million recorded during the first quarter of 2017, which were in excess of the carrying value of our Tranche 1 investment. See Note 7 to our condensed consolidated financial statements.

Interest expense – NCM. We recorded non-cash interest expense of $5.0 million for the first quarter of 2018 related to the significant financing component associated with certain of our agreements with NCM. See Note 3 to our condensed consolidated financial statements for further discussion.

Equity in Income of Affiliates. We recorded equity in income of affiliates of $8.6 million during the first quarter of 2018 compared to $10.1 million during the first quarter of 2017. See Notes 7 and 8 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. Income tax expense of $25.1 million was recorded for the first quarter of 2018 compared to $44.4 million recorded for the first quarter of 2017. The effective tax rate was approximately 28.8% for the first quarter of 2018 compared to 35.6% for the first quarter of 2017. The effective tax rate in 2018 benefited from a lower U.S. federal tax rate. On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, and (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries.

As of March 31, 2018, the amounts recorded for the Tax Act remain provisional for the transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. These estimates may be impacted by further analysis due to future clarification and guidance regarding earnings and profits computations, state tax conformity to federal tax changes, and potential tax planning options under consideration.

Income tax provisions for interim (quarterly) periods are based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. In addition, nearly all of our theatres provide the patron a choice of using a credit card, debit card or advanced-sale type certificates such as a gift card, in place of cash. Because our revenues are received in cash prior to the payment of related expenses, we have an operating “float” and historically have not required traditional working capital financing. Cash provided by operating activities was $83.7 million for the three months ended March 31, 2018 compared to $150.6 million for the three months ended March 31, 2017. The decrease in cash provided by operating activities was primarily due to the decrease in net income and the timing of payments to suppliers.

Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $78.9 million for the three months ended March 31, 2018 compared to $87.6 million for the three months ended March 31, 2017. The decrease was primarily due to a decrease in capital expenditures related to the remodel of certain of our existing domestic theatres.

Capital expenditures for the three months ended March 31, 2018 and 2017 were as follows (in millions):

Capital expenditures for existing properties in the table above includes the costs of remodeling certain of our existing theatres to include Luxury Loungers and expanded concession offerings. During the three months ended March 31, 2018 and 2017, we had an average of 80 and 106 of our domestic screens, respectively, temporarily closed for such remodels.

Our U.S. theatre circuit consisted of 339 theatres with 4,566 screens at March 31, 2018. During the three months ended March 31, 2018, we built one new theatre and 12 screens and closed one theatre with seven screens. At March 31, 2018, we had signed commitments to open three new theatres and 30 screens in domestic markets during the remainder of 2018 and open nine new theatres with 94 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 124 domestic screens will be approximately $91 million.

Our international theatre circuit consisted of 194 theatres with 1,398 screens at March 31, 2018. At March 31, 2018, we had signed commitments to open nine new theatres and 49 screens in international markets during the remainder of 2018 and open two new theatres and 12 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 61 international screens will be approximately $37 million.

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, and proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Cash used for financing activities was $53.4 million for the three months ended March 31, 2018 compared to $41.7 million for the three months ended March 31, 2017. The increase was primarily due to the payment of debt issuance costs associated with the amendment of our senior secured credit facility (see Note 5 to our condensed consolidated financial statements) and the increase in the quarterly cash dividend from $0.29 to $0.32 per share of common stock.

We, at the discretion of the board of directors and subject to applicable law, anticipate paying regular quarterly dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash balance, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, future prospects for earnings and cash flows, as well as other relevant factors.

We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities. Long-term debt consisted of the following as of March 31, 2018 (in millions):

As of March 31, 2018, Cinemark USA, Inc. had $100.0 million in available borrowing capacity on its revolving credit line.

In March 2018, Cinemark USA, Inc. amended its senior secured credit facility, which extended the maturity of the term loan to March 2025. Included below is an updated summary of long-term debt obligations and related estimated scheduled interest payment obligations as of March 31, 2018, reflecting the amended agreement.

There have been no other material changes in our contractual obligations previously disclosed in “Liquidity and Capital Resources” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed February 23, 2018.

Other than operating leases and purchase commitments disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017 filed February 23, 2018, we do not have any off-balance sheet arrangements.

Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan, with a maturity date of March 2025, and a $100.0 million revolving credit line, with a maturity date of December 2022 (collectively referred to as the “Credit Agreement”).

On March 29, 2018, Cinemark USA, Inc., amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025.

Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of March 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,681.5 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Credit Agreement, subject to its available cash and other borrowing restrictions outlined in the agreement.

At March 31, 2018, there was $657.9 million outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had $100.0 million in available borrowing capacity on the revolving credit line. The average interest rate on outstanding term loan borrowings under the Credit Agreement at March 31, 2018 was approximately 3.8% per annum.

On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

The indenture to the 5.125% Senior Notes contains covenants including limitations on the amount of dividends that could be paid by Cinemark USA, Inc. As of March 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,528.7 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of March 31, 2018 was approximately 5.9 to 1.

On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% Senior Notes due 2023, at par value (the “4.875% Senior Notes”). On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate principal amount of the 4.875% Senior Notes at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s $200.0 million 7.375% Senior Subordinated Notes. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as the Company’s existing 4.875% Senior Notes. Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023.

The indenture to the 4.875% Senior Notes contains covenants that include limitations on the amount of dividends that Cinemark USA, Inc. can pay. As of March 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,523.5 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of March 31, 2018 was approximately 5.9 to 1.

As of March 31, 2018, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. Generally, the most successful motion pictures have been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can impact this seasonality trend. The timing and quality of film releases can have a significant impact on our results of operations, and the results of one period are not necessarily indicative of results for the following period or for the same period in the following year.

We have exposure to financial market risks, including changes in interest rates, foreign currency exchange rates and other relevant market prices.

We are currently party to a variable rate debt facility. An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt. At March 31, 2018, we had an aggregate of approximately $657.9 million of variable rate debt outstanding. Based on the interest rates in effect on the variable rate debt outstanding at March 31, 2018, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $6.6 million.

The table below provides information about our fixed rate and variable rate long-term debt agreements as of March 31, 2018:

	Expected Maturity for the Twelve-Month Periods Ending March 31,																Average
	(in millions)																Interest
	2019		2020		2021		2022		2023		Thereafter		Total		Fair Value		Rate
Fixed rate	$	1.4	$	1.4	$	—	$	—	$	400.0	$	755.0	$	1,157.8	$	1,155.4		5.0	%
Variable rate		6.6		6.6		6.6		6.6		6.6		624.9		657.9		659.5		3.8	%
Total debt	$	8.0	$	8.0	$	6.6	$	6.6	$	406.6	$	1,379.9	$	1,815.7	$	1,814.9

Other than the devaluation of the Argentine peso, discussed in Note 13 to the condensed consolidated financial statements, there have been no material changes in foreign currency exchange rate risk previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed February 23, 2018.

As of March 31, 2018, we carried out an evaluation required by the Exchange Act, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2018, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended March 31, 2018 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no material changes from legal proceedings previously reported under “Business – Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed February 23, 2018.

There have been no material changes from risk factors previously disclosed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed February 23, 2018.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Delaware		20-5490327
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3900 Dallas Parkway
Suite 500
Plano, Texas		75093
(Address of principal executive offices)		(Zip Code)

			Page
PART I. FINANCIAL INFORMATION

	Item 1.	Financial Statements	4

		Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017 (unaudited)	4

		Condensed Consolidated Statements of Income for the three months ended March 31, 2018 and 2017 (unaudited)	5

		Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2018 and 2017 (unaudited)	6

		Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2018 and 2017 (unaudited)	7

		Notes to Condensed Consolidated Financial Statements (unaudited)	8

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	25

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	34

	Item 4.	Controls and Procedures	34

PART II. OTHER INFORMATION

	Item 1.	Legal Proceedings	35

	Item 1A.	Risk Factors	35

	Item 6.	Exhibits	36

SIGNATURES			37

	Three Months Ended March 31,
	2018			2017
Net income	$	62,177		$	80,194
Other comprehensive income, net of tax
Other comprehensive income in equity method investments		136			198
Foreign currency translation adjustments		204			14,893
Total other comprehensive income, net of tax		340			15,091
Total comprehensive income, net of tax		62,517			95,285
Comprehensive income attributable to noncontrolling interests		(156	)		(466	)
Comprehensive income attributable to Cinemark Holdings, Inc.	$	62,361		$	94,819

	U.S.		International
	Operating		Operating
	Segment ⁽¹⁾		Segment		Consolidated
Goods and services transferred at a point in time	$	575,826	$	166,149	$	741,975
Goods and services transferred over time		20,517		17,479		37,996
Total	$	596,343	$	183,628	$	779,971

	Three Months Ended			Three Months Ended
	March 29, 2018			March 30, 2017
Gross revenues	$	80,200		$	71,900
Operating income	$	11,000		$	5,100
Net income (loss)	$	(3,000	)	$	(7,900	)

	As of			As of
	March 29, 2018			December 28, 2017
Current assets	$	127,500		$	174,400
Noncurrent assets	$	765,400		$	758,300
Current liabilities	$	64,500		$	123,300
Noncurrent liabilities	$	948,100		$	925,400
Members deficit	$	(119,700	)	$	(116,000	)

	Three Months Ended
	March 31, 2018		March 31, 2017
Gross revenues	$	41,033	$	45,479
Operating income	$	23,445	$	27,934
Net income	$	21,534	$	24,142

	Number of
	Treasury
	Shares		Cost
Balance at January 1, 2018		4,525,870	$	76,354
Restricted stock withholdings ⁽¹⁾		70,010		2,695
Restricted stock forfeitures		11,303		—
Balance at March 31, 2018		4,607,183	$	79,049

	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2018		650,581		$	35.81
Granted		260,019		$	39.03
Vested		(202,341	)	$	29.45
Forfeited		(11,303	)	$	37.96
Outstanding at March 31, 2018		696,956		$	38.82
Unvested restricted stock at March 31, 2018		696,956		$	38.82

	Number of
	Shares		Value at
	Vesting		Grant
at IRR of at least 7%		74,867	$	2,922
at IRR of at least 9.5%		149,735	$	5,844
at IRR of at least 13%		224,602	$	8,766

	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2018 ⁽¹⁾	$	1,174,041	$	110,038		$	1,284,079
Foreign currency translation adjustments		—		(134	)		(134	)
Balance at March 31, 2018⁽¹⁾	$	1,174,041	$	109,904		$	1,283,945

For the nine months ended December 31, 2018	$	4,104
For the twelve months ended December 31, 2019		5,267
For the twelve months ended December 31, 2020		5,535
For the twelve months ended December 31, 2021		3,685
For the twelve months ended December 31, 2022		3,280
Thereafter		13,535
Total	$	35,406

	As of		As of
Theatre Properties and Equipment-net	March 31, 2018		December 31, 2017
U.S.	$	1,450,758	$	1,439,168
Brazil		174,341		179,669
Other international countries		210,553		209,217
Total	$	1,835,652	$	1,828,054

Cinemark USA, Inc. term loan	$	657.9
Cinemark USA, Inc. 5.125% senior notes due 2022		400.0
Cinemark USA, Inc. 4.875% senior notes due 2023		755.0
Other	2.8
Total long-term debt	$	1,815.7
Less current portion		8.0
Subtotal long-term debt, less current portion	$	1,807.7
Less: Debt discounts and debt issuance costs, net of accumulated amortization		32.4
Long-term debt, less current portion, net of debt issuance costs	$	1,775.3

	Payments Due by Period
	(in millions)
			Less Than						After
Contractual Obligations	Total		One Year		1 - 3 Years		3 - 5 Years		5 Years
Long-term debt ⁽¹⁾	$	1,815.7	$	8.0	$	14.6	$	413.2	$	1,379.9
Scheduled interest payments on long-term debt⁽²⁾	$	426.0	$	82.0	$	163.0	$	134.5	$	46.5

*31.1		Certification of Mark Zoradi, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

*31.2		Certification of Sean Gamble, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

*32.1		Certification of Mark Zoradi, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

*32.2		Certification of Sean Gamble, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

* 101		Financial Statements from the quarterly report on Form 10-Q of Cinemark Holdings, Inc. for the quarter ended March 31, 2018, filed May 9, 2018, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements tagged as detailed text.

		CINEMARK HOLDINGS, INC.
		Registrant

DATE:	May 9, 2018

		/s/Mark Zoradi
		Mark Zoradi
		Chief Executive Officer

		/s/Sean Gamble
		Sean Gamble
		Chief Financial Officer